544 related articles for article (PubMed ID: 17363567)
21. Leptin induces cyclin D1 expression and proliferation of human nucleus pulposus cells via JAK/STAT, PI3K/Akt and MEK/ERK pathways.
Li Z; Shen J; Wu WK; Yu X; Liang J; Qiu G; Liu J
PLoS One; 2012; 7(12):e53176. PubMed ID: 23300886
[TBL] [Abstract][Full Text] [Related]
22. Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways.
Chen C; Chang YC; Lan MS; Breslin M
Int J Oncol; 2013 Mar; 42(3):1113-9. PubMed ID: 23354006
[TBL] [Abstract][Full Text] [Related]
23. Circular RNA circCDK13 suppresses cell proliferation, migration and invasion by modulating the JAK/STAT and PI3K/AKT pathways in liver cancer.
Lin Q; Ling YB; Chen JW; Zhou CR; Chen J; Li X; Huang MS
Int J Oncol; 2018 Jul; 53(1):246-256. PubMed ID: 29658568
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Su C; Chen J
Cancer Lett; 2013 Sep; 337(2):226-36. PubMed ID: 23684551
[TBL] [Abstract][Full Text] [Related]
25. Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation.
Liu Y; Lv L; Xiao W; Gong C; Yin J; Wang D; Sheng H
J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):365. PubMed ID: 21671179
[TBL] [Abstract][Full Text] [Related]
26. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
[TBL] [Abstract][Full Text] [Related]
27. Regulating RISK: a role for JAK-STAT signaling in postconditioning?
Goodman MD; Koch SE; Fuller-Bicer GA; Butler KL
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1649-56. PubMed ID: 18708442
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of PI3K/Akt and ERK signaling decreases visfatin-induced invasion in liver cancer cells.
Miethe C; Torres L; Zamora M; Price RS
Horm Mol Biol Clin Investig; 2021 Aug; 42(4):357-366. PubMed ID: 34449178
[TBL] [Abstract][Full Text] [Related]
29. LncRNA ANRIL promotes cell growth, migration and invasion of hepatocellular carcinoma cells via sponging miR-144.
Ma Y; Zhang H; Li G; Hu J; Liu X; Lin L
Anticancer Drugs; 2019 Nov; 30(10):1013-1021. PubMed ID: 31609763
[TBL] [Abstract][Full Text] [Related]
30. APPL1-Mediating Leptin Signaling Contributes to Proliferation and Migration of Cancer Cells.
Ding Y; Cao Y; Wang B; Wang L; Zhang Y; Zhang D; Chen X; Li M; Wang C
PLoS One; 2016; 11(11):e0166172. PubMed ID: 27820851
[TBL] [Abstract][Full Text] [Related]
31. Bisphenol A induces leptin receptor expression, creating more binding sites for leptin, and activates the JAK/Stat, MAPK/ERK and PI3K/Akt signalling pathways in human ovarian cancer cell.
Ptak A; Gregoraszczuk EL
Toxicol Lett; 2012 May; 210(3):332-7. PubMed ID: 22343039
[TBL] [Abstract][Full Text] [Related]
32. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.
Stefanou N; Papanikolaou V; Furukawa Y; Nakamura Y; Tsezou A
BMC Cancer; 2010 Aug; 10():442. PubMed ID: 20723213
[TBL] [Abstract][Full Text] [Related]
33. Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinoma.
Hennig M; Yip-Schneider MT; Klein P; Wentz S; Matos JM; Doyle C; Choi J; Wu H; O'Mara A; Menze A; Noble S; McKillop IH; Schmidt CM
J Surg Res; 2009 Jun; 154(2):187-95. PubMed ID: 19321179
[TBL] [Abstract][Full Text] [Related]
34. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway.
Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX
Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814
[TBL] [Abstract][Full Text] [Related]
35. cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells.
Fu H; He Y; Qi L; Chen L; Luo Y; Chen L; Li Y; Zhang N; Guo H
Cancer Lett; 2017 Sep; 403():260-270. PubMed ID: 28649002
[TBL] [Abstract][Full Text] [Related]
36. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.
Zhang Z; Zhu J; Huang Y; Li W; Cheng H
Diagn Pathol; 2018 Nov; 13(1):85. PubMed ID: 30390677
[TBL] [Abstract][Full Text] [Related]
37. [The effect of leptin and its mechanisms on the migration and invasion of human breast cancer MCF-7 cells].
Wang L; Cao H; Pang X; Li K; Dang W; Tang H; Chen T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Dec; 29(12):1272-6. PubMed ID: 24321071
[TBL] [Abstract][Full Text] [Related]
38. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation.
Ogunwobi O; Mutungi G; Beales IL
Endocrinology; 2006 Sep; 147(9):4505-16. PubMed ID: 16740977
[TBL] [Abstract][Full Text] [Related]
39. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3.
Zhou Y; Li Y; Xu S; Lu J; Zhu Z; Chen S; Tan Y; He P; Xu J; Proud CG; Xie J; Shen K
Int J Cancer; 2020 Mar; 146(5):1383-1395. PubMed ID: 31286509
[TBL] [Abstract][Full Text] [Related]
40. Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway.
Matsushima-Nishiwaki R; Toyoda H; Takamatsu R; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Yoshimi N; Kumada T; Kozawa O
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1629-1639. PubMed ID: 28456666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]